Figure 1.
Targeted therapies for PD: from genetics to the clinic. Discovery of genes implicated in PD and subsequent understanding of their physiopathological roles provide the foundation for these genetic-based therapeutic approaches. Large natural history studies, novel biomarker discovery, and disease modeling can help design clinical trials targeting specific patient populations and suitable endpoints.